2023 / 01

Next Paper
DOI: 10.24075/medet.2023.002

REVIEW

The trouble with antibiotics

Palyutin ShH, Zilber IE, Pozdnyakov NO, Sinitsina OA, Speshilova SA, Sirotkina AM
About authors

Yaroslavl State Medical University, Yaroslavl, Russia

Correspondence should be addressed: Shamil Kh. Palyutin
ul. Revolutsionnaya, 5, Yaroslavl, 150000, Russia; ur.xednay@ocimahs

About paper

Author contribution: Speshilova SA — research planning, data collection, data analysis, data interpretation, preparing a manuscript draft, article concept, literature selection and analysis, data generalization, text writing; Sinitsina OA — research planning, data selection and analysis; Demarina SM — preparing a list of literature; Palyutin ShKh — literature selection and analysis, data generalization, text writing.

Received: 2022-12-21 Accepted: 2023-01-20 Published online: 2023-02-25
|
  1. O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. London: Review on Antimicrobial Resistance, 2014.
  2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance, 2016.
  3. de Kraker MEA, Stewardson AJ, Harbarth S (2016) Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS Med. 13 (11): e1002184.
  4. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629–55. Published Online January 20, 2022.
  5. Chedid M, Waked R, Haddad E, Chetata N, Saliba G, Choucair J. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy. J Infect Public Health. 2021 May; 14 (5): 570–576.
  6. Rodríguez-Baño, Jesús et al. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Transactions of the Royal Society of Tropical Medicine and Hygiene, trab048. 27 Mar. 2021.
  7. Mustafa ZU, Saleem MS, Ikram MN, Salman M, Butt SA, Khan S, Godman B, Seaton RA. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey. Pathog Glob Health. 2022 Oct;116(7):421–427.
  8. Schons MJ, Caliebe A, Spinner CD, Classen AY, Pilgram L, Ruethrich MM, Rupp J, Nunes de Miranda SM, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degenhardt C, Borgmann S, Hower M, Hanses F, Haselberger M, Friedrichs AK; LEOSS-study group. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort. Infection. 2022 Apr; 50 (2): 423–436.
  9. Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018 Apr 10; 115 (15): E3463–E3470.
  10. Buehrle DJ, Nguyen MH, Wagener MM, Clancy CJ. Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States. Open Forum Infect Dis. 2020 Dec 22; 7 (12): ofaa575.
  11. Vaduganathan M, van Meijgaard J, Mehra MR, et al. Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States. JAMA 2020; 323: 2524–6.
  12. O primenenii antibakterial’noy terapii u patsientov s novoy koronavirusnoy infektsiey COVID-19. Sovmestnoe obrashchenie k vrachebnomu soobshchestvu Rossii. 2020. Available from URL: https://antimicrob.net/o-primenenii-antibakterialnoy-tera/.
  13. Doguzova V. Prodazhi antibiotikov v aptekakh sokratilis’ bolee chem na 10%. Farmatsevticheskiy vestnik. 2022. Available from URL: https://pharmvestnik.ru/content/news/ Prodaji-antibiotikov-v-aptekah-sokratilis-bolee-chem-na-10.html.
  14. Mahida N, Winzor G, Wilkinson M, Jumaa P, Gray J. Antimicrobial stewardship in the post COVID-19 pandemic era: an opportunity for renewed focus on controlling the threat of antimicrobial resistance. J Hosp Infect. 2022 Nov; 129: 121–123.
  15. WHO. 2015. Global action plan on antimicrobial resistance. Available from URL: http://www.who.int/drugresistance/global_action_plan/en/
  16. Lynch C, Mahida N, Gray J. Antimicrobial stewardship: a COVID casualty? J Hosp Infect. 2020; 206: 401–403.
  17. Laxminarayan R, Van Boeckel T, Frost I, Kariuki S, Khan EA, Limmathurotsakul D, et al. The Lancet infectious diseases Commission on antimicrobial resistance: 6 years later. Lancet Infect Dis. 2020; 20: e51-e60.
  18. Yip C, Lee AJ. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature. Clin Ther. 2006 Nov; 28 (11): 1857–66.
  19. Zvonar R. Gatifloxacin-induced dysglycemia. Am J Health Syst Pharm. 2006 Nov 1; 63 (21): 2087–92.
  20. Available from URL: http://roszdravnadzor.gov.ru›i/upload/images/2019/2/12/
  21. Available from URL: http://www.fda.gov/OHRMS/DOCKETS/98fr/cd07129-n.pdf
  22. Two drugs banned. The HINDU. 2011. Available from URL: http://www.thehindu.com/news/nationaI/article1551233.ece.